Public Profile

Coloplast

Coloplast A/S, a leading global healthcare company headquartered in Denmark (DK), specialises in innovative medical devices and services for individuals with intimate healthcare needs. Founded in 1957, Coloplast has established a strong presence in Europe, North America, and Asia, focusing on areas such as ostomy care, continence care, and wound and skin care. The company is renowned for its commitment to user-friendly products, including advanced ostomy bags and continence management solutions that enhance the quality of life for patients. Coloplast's dedication to research and development has positioned it as a market leader, with notable achievements in product innovation and patient support services. With a strong emphasis on sustainability and social responsibility, Coloplast continues to make significant strides in the healthcare industry, ensuring that individuals receive the best possible care.

DitchCarbon Score

How does Coloplast's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

27

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

13

Industry Benchmark

Coloplast's score of 27 is higher than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.

92%

Coloplast's reported carbon emissions

In 2023, Coloplast A/S reported total carbon emissions of approximately 197,000,000 kg CO2e. This includes about 21,670,000 kg CO2e from Scope 1 emissions, which encompass direct emissions from owned or controlled sources, and approximately 21,670,000 kg CO2e from Scope 2 emissions, related to indirect emissions from the generation of purchased electricity. The company also reported about 158,200,000 kg CO2e in Scope 3 emissions, which cover all other indirect emissions in the value chain. Coloplast has set ambitious climate commitments, aiming to achieve a 100% reduction in absolute Scope 1 and 2 greenhouse gas emissions by FY2030, using FY2019 as the baseline year. Additionally, the company is committed to sourcing 100% renewable electricity annually through 2025. For Scope 3 emissions, Coloplast targets a 50% reduction per product manufactured by FY2030, also from a FY2019 baseline. These commitments align with the Science Based Targets initiative (SBTi) and reflect Coloplast's dedication to sustainability within the healthcare equipment and supplies sector, headquartered in Denmark (DK).

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

Add to project
2007200820092010201120122015201620172018201920202021202220232024
Scope 1
15,000,000
00,000,000
00,000,000
00,000,000
00,000,000
0,000,000
0,000,000
0,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
000,000,000
Scope 2
36,404,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
-
-
-
-
-
000,000,000
Scope 3
7,398,000
0,000,000
00,000,000
00,000,000
00,000,000
00,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Coloplast's primary industry is Medical, precision and optical instruments, watches and clocks (33), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Coloplast is headquartered in DK, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Coloplast is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Medical Device Manufacturing

Thorlabs Measurement Systems Inc.

US
Medical Device Manufacturing
Updated 3 days ago

Sterling Pharma Solutions

GB
Medical Device Manufacturing
Updated 10 days ago

B. Braun Canada Ltd.

CA
Medical Device Manufacturing
Updated 10 days ago

Médecins sans frontières

CH
Medical Device Manufacturing
Updated 10 days ago

Tianyi Medical Appliances

CN
Medical Device Manufacturing
Updated 10 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers